These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 19060179

  • 1. Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines.
    Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, Köhrle J, Dralle H, Hoang-Vu C.
    J Mol Endocrinol; 2009 Mar; 42(3):249-60. PubMed ID: 19060179
    [Abstract] [Full Text] [Related]

  • 2. Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma.
    Trojanowicz B, Sekulla C, Lorenz K, Köhrle J, Finke R, Dralle H, Hoang-Vu C.
    Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):110-7. PubMed ID: 20538039
    [Abstract] [Full Text] [Related]

  • 3. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
    Ejeskär K, Krona C, Carén H, Zaibak F, Li L, Martinsson T, Ioannou PA.
    BMC Cancer; 2005 Dec 16; 5():161. PubMed ID: 16359544
    [Abstract] [Full Text] [Related]

  • 4. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
    Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A.
    Mol Cell Endocrinol; 2007 Jan 29; 264(1-2):74-81. PubMed ID: 17101211
    [Abstract] [Full Text] [Related]

  • 5. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H, Liu T, Yang JL, Huang X, Liu B, Song X, Zhao X, Wei YQ.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 27; 87(8):520-5. PubMed ID: 17459200
    [Abstract] [Full Text] [Related]

  • 6. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.
    Tsai ST, Chien IH, Shen WH, Kuo YZ, Jin YT, Wong TY, Hsiao JR, Wang HP, Shih NY, Wu LW.
    Eur J Cancer; 2010 Jun 27; 46(9):1712-23. PubMed ID: 20435467
    [Abstract] [Full Text] [Related]

  • 7. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
    Zhang M, Guo R, Xu H, Zhang M, Li B.
    Nucl Med Commun; 2011 Jul 27; 32(7):605-10. PubMed ID: 21471848
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells.
    Yan GR, Xu SH, Tan ZL, Yin XF, He QY.
    Proteomics; 2011 Sep 27; 11(18):3657-64. PubMed ID: 21751384
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.
    Sedoris KC, Thomas SD, Miller DM.
    Biochemistry; 2007 Jul 24; 46(29):8659-68. PubMed ID: 17595061
    [Abstract] [Full Text] [Related]

  • 13. Proteomic analysis of secreted proteins of non-small cell lung cancer.
    Huang LJ, Chen SX, Luo WJ, Jiang HH, Zhang PF, Yi H.
    Ai Zheng; 2006 Nov 24; 25(11):1361-7. PubMed ID: 17094902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discovery and validation of protein abundance differences between follicular thyroid neoplasms.
    Netea-Maier RT, Hunsucker SW, Hoevenaars BM, Helmke SM, Slootweg PJ, Hermus AR, Haugen BR, Duncan MW.
    Cancer Res; 2008 Mar 01; 68(5):1572-80. PubMed ID: 18316623
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M.
    Int J Oncol; 2008 Oct 01; 33(4):725-31. PubMed ID: 18813785
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
    Shih NY, Lai HL, Chang GC, Lin HC, Wu YC, Liu JM, Liu KJ, Tseng SW.
    Jpn J Clin Oncol; 2010 Jul 01; 40(7):663-9. PubMed ID: 20395242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.